Latest News
Trex Company, Inc.
- Trex stock hits 52-week high at 51.03 USD By Investing.com
- Operating margin % of Trex SA – GPW:TRX
- Form 4 TRex Bio: Joel S. Marcus (Director) For: 13 October
- TREX Awards 2027: The hunt begins for travel retail-exclusive excellence as entries open
- TRex Bio prices $117M IPO to support immune drug work
- Lilly-backed TRex rakes in $117M IPO, while hypertension biotech Retension reveals $45M listing
- TRex prices IPO at bottom of range as Retension makes its public debut
- TRex Bio, Clinical-Stage Immunology Biopharma, Files for Nasdaq Global Select Market IPO
- TRex Bio sets terms for Nasdaq IPO of up to $128.7 million, with Lilly eyeing stake
- TRex Bio stomps toward $111M IPO, as Retension and Lycia also gear up to go public
- Immunology startup TRex Bio sets price range for $133 million public debut
- In test of investors' appetite, Lilly-connected TRex Bio plots $153 million IPO
Headlines from the last 30 days, linking to the original publishers. See all market news →